MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, EBS has $1,320,400K in assets. $797,300K in debts. $160,300K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
428.78%
Quick Ratio
208.47%
Cash Ratio
107.80%
Debt to Asset Ratio
60.38%
Unit: Thousand (K) dollars
Assets Breakdown
    • Intangible assets, net
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Treasury stock, at cost, 9.6 and...
    • Accumulated deficit
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
160,300 205,400 245,500 267,300
Restricted cash
1,200 3,700 3,700 3,700
Accounts receivable, net
121,600 84,200 149,500 79,800
Inventories, net
327,600 343,400 356,300 338,600
Prepaid expenses and other current assets
26,900 25,800 25,600 24,000
Assets held for sale
--6,300 6,100
Total current assets
637,600 662,500 786,900 719,500
Property, plant and equipment, net
199,400 205,400 209,800 216,100
Intangible assets, net
470,400 436,500 452,700 469,000
Other assets
13,000 14,200 11,600 12,500
Total assets
1,320,400 1,318,600 1,461,000 1,417,100
Accounts payable
39,500 55,600 57,400 63,700
Liabilities held for sale
--4,500 4,700
Accrued expenses
9,400 12,200 13,900 13,600
Accrued compensation
22,000 41,800 36,600 31,500
Accrued acquisition obligation
50,400 ---
Deferred revenue
12,200 ---
Current tax liability
7,200 6,800 --
Other current liabilities
8,000 15,800 24,100 13,600
Total current liabilities
148,700 132,200 136,500 127,100
Debt
573,600 572,100 663,100 667,800
Deferred tax liability
33,300 37,800 36,300 46,500
Other liabilities
41,700 53,900 42,600 39,500
Total liabilities
797,300 796,000 878,500 880,900
Common stock, 0.001 par value per share 200.0 shares authorized, 61.4 and 60.9 shares issued 51.8 and 52.1 shares outstanding, respectively
100 100 100 100
Treasury stock, at cost, 9.6 and 8.7 common shares, respectively
261,600 252,600 243,500 234,600
Additional paid-in capital
944,500 942,400 938,600 935,200
Accumulated other comprehensive loss, net
-6,900 -7,500 -7,500 -8,100
Accumulated deficit
-153,000 -159,800 -105,200 -156,400
Total stockholders equity
523,100 522,600 582,500 536,200
Total liabilities and stockholders equity
1,320,400 1,318,600 1,461,000 1,417,100
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Inventories, net$327,600K Cash and cashequivalents$160,300K Accounts receivable, net$121,600K Prepaid expenses andother current assets$26,900K Restricted cash$1,200K Total current assets$637,600K Intangible assets, net$470,400K Property, plant andequipment, net$199,400K Other assets$13,000K Total assets$1,320,400K Total liabilities andstockholders equity$1,320,400K Total liabilities$797,300K Total stockholdersequity$523,100K Treasury stock, at cost,9.6 and 8.7 common...$261,600K Accumulated deficit-$153,000K Accumulated othercomprehensive loss, net-$6,900K Debt$573,600K Total currentliabilities$148,700K Other liabilities$41,700K Deferred tax liability$33,300K Additional paid-in capital$944,500K Common stock, 0.001 parvalue per share 200.0...$100K Accrued acquisitionobligation$50,400K Accounts payable$39,500K Accrued compensation$22,000K Deferred revenue$12,200K Accrued expenses$9,400K Other currentliabilities$8,000K Current tax liability$7,200K

Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Inc. (EBS)